View Single Post
fema4psychiatrists
Member
 
fema4psychiatrists's Avatar
fema4psychiatrists has no updates.
 
Member Since: Oct 2016
Location: London
Posts: 72
5 yr Member
1 hugs
given
Default May 08, 2017 at 05:43 AM
 
This is off the drug companies website. Do be aware they manipulate data.

https://www.gsksource.com/pharma/con...MG.PDF#page=10

Glaxo were fined billions of dollars by the US court of supreme justice:

https://www.justice.gov/opa/pr/glaxo...failure-report

One of the whistleblowers from that trial talks about Wellbutrin. And about how he would get doctors to sell it to patients with the quotes he was telling them to as a GSK sales drug rep. that includes 'Wellbutrin is the happy horny skinny antidepressant' or something.

Start at 7 minutes and 41 seconds in if you feel like

https://youtu.be/y_RJ9QPG70U?t=7m41s

It is better to be armed with knowledge now, than be stuck later, or take a drug you wouldn't want to and have not been informed about what it is.

Wellbutrin clashes with MAOI's (blood thinners) and most commonly causes adverse effects of agitation and insomnia. In the literature. I assume it must be another form of stimulant drug.

See more on this multi-studied study of antidepressant-induced sexual dysfunctions comparing the percentages of the different antidepressant drugs.

"Montjo-Gonzales et al10 reported an overall incidence of 58% in an unblinded study involving 344 clients who had a history of normal sexual function before SSRI treatments. The frequency of sexual side effects was highest for paroxetine (65%), fluvoxamine (59%), sertaline (56%) and fluoxetine (54%). In a multicenter, prospective, Spanish study involving 1022 people, Montejo et al12 reported a 59.1% overall incidence of sexual dysfunction when all antidepressants were considered as a whole. The differences between drugs are summarized in Table 1 and were as follows: incidence of sexual dysfunction with SSRIs and venlafaxine (an SNRI) were high ranging between 58% and 70% – fluoxetine (57.7%), sertaline (62.9%), fluvoxamine (62.3%), venlafaxine (67%), paroxetine (70.7%), and citalopram (72.7%). This compared with a much lower incidence for the newer 5-HT2 blockers (8% nefazodone and 24% mirtazapine). Moclobemide, a reversible MAOI, (3.9%) resulted in the lowest incidence of sexual dysfunction. When differences between men and women were compared, men reported a slightly higher frequency of sexual dysfunction than women (62% and 60%). Clayton et al,13 in an adult outpatient population (4534 women and 1763 men) receiving antidepressant monotherapy, reported rates of sexual dysfunction as follows: mirtazapine and venlafaxine extended release were associated with higher rates (36%–43%), followed by nefazodone (28%), bupropion SR (25%) and bupropion IR (22%)."

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108697/

__________________
Information on Post SSRI Sexual Dysfunction (PSSD) at pssdblog.blogspot.co.uk That's irreversible Impotence caused by psychiatric medications. Needs more research to protect mentally ill patients.

Last edited by fema4psychiatrists; May 08, 2017 at 06:02 AM..
fema4psychiatrists is offline   Reply With QuoteReply With Quote